3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
7
Urinary Bladder Neoplasms
5
Glioma
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Esophageal Neoplasms
4
Burkitt Lymphoma
4
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Astrocytoma
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Ganglioneuroblastoma
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
Biopsy
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
larotrectinib
2
erdafitinib
2
ensartinib
2
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
palbociclib
1
olaparib
1
niraparib
1
ivosidenib
1
elacestrant
1
cabozantinib
1
alectinib
1
abemaciclib
1
Vincristine
1
Vinblastine
1
Vemurafenib
1
Topotecan
1
Temozolomide
1
RAD1901
1
Methotrexate
1
LY3023414
1
Induction Chemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Radiation
×
30 days
×
Clear all
No trials found.